Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

Fig. 2

Lipase mass concentration during coadministration of three drugs in group 1. aLPL mass concentration. bEL mass concentration. White indicates the baseline. Blue indicates the second blood sampling when rosuvastatin was administered at 20 mg/day. Pink indicates the third blood sampling when rosuvastatin at 20 mg/day and ezetimibe at 10 mg/day were coadministered. Purple indicates the last blood sampling when rosuvastatin at 20 mg/day, ezetimibe at 10 mg/day, and colestimide at 3.62 g/day were coadministered

Back to article page